• Complain

Marc E. Grossman - Cutaneous Manifestations of Infection in the Immunocompromised Host

Here you can read online Marc E. Grossman - Cutaneous Manifestations of Infection in the Immunocompromised Host full text of the book (entire story) in english for free. Download pdf and epub, get meaning, cover and reviews about this ebook. year: 2012, publisher: Springer Verlag, genre: Home and family. Description of the work, (preface) as well as reviews are available. Best literature library LitArk.com created for fans of good reading and offers a wide selection of genres:

Romance novel Science fiction Adventure Detective Science History Home and family Prose Art Politics Computer Non-fiction Religion Business Children Humor

Choose a favorite category and find really read worthwhile books. Enjoy immersion in the world of imagination, feel the emotions of the characters or learn something new for yourself, make an fascinating discovery.

Marc E. Grossman Cutaneous Manifestations of Infection in the Immunocompromised Host

Cutaneous Manifestations of Infection in the Immunocompromised Host: summary, description and annotation

We offer to read an annotation, description, summary or preface (depends on what the author of the book "Cutaneous Manifestations of Infection in the Immunocompromised Host" wrote himself). If you haven't found the necessary information about the book — write in the comments, we will try to find it.

The updated second edition of Cutaneous Manifestations of Infection in the Immunocompromised Host is an invaluable reference for physicians and ancillary medical professionals involved in the care of patients with impaired immune systems due to cancer, chemotherapy, systemic steroids and other immunosuppressive drugs, HIV/AIDS or organ transplantation. This volume will help you recognize skin lesions and diagnose their infectious cause. Textbook features include:

Over 350 color images demonstrating pathognomonic, atypical, rare and routine skin lesions

Tables for differential diagnosis of different skin lesions in the immunocompromised host

Complete coverage of infectious pathogens with the patterns of infection and the likely causes in different clinical settings (HIV/AIDS versus solid organ transplantation versus neutropenia post-chemotherapy versus bone marrow recovery post hematopoietic stem cell transplantation )

New chapter discussing the role of viruses causing malignancies with cutaneous signs in the immunocompromised patient

Written by dermatologists, the new edition is an indispensable diagnostic tool intended for use by all clinicians who care for immunocompromised patients.

Marc E. Grossman: author's other books


Who wrote Cutaneous Manifestations of Infection in the Immunocompromised Host? Find out the surname, the name of the author of the book and a list of all author's works by series.

Cutaneous Manifestations of Infection in the Immunocompromised Host — read online for free the complete book (whole text) full work

Below is the text of the book, divided by pages. System saving the place of the last page read, allows you to conveniently read the book "Cutaneous Manifestations of Infection in the Immunocompromised Host" online for free, without having to search again every time where you left off. Put a bookmark, and you can go to the page where you finished reading at any time.

Light

Font size:

Reset

Interval:

Bookmark:

Make
Marc E. Grossman , Lindy P. Fox , Carrie Kovarik and Misha Rosenbach Cutaneous Manifestations of Infection in the Immunocompromised Host Second Edition 10.1007/978-1-4419-1578-8_1 Springer Science+Business Media, LLC 2012
1. Subcutaneous and Deep Mycoses
Marc E. Grossman 1, Lindy P. Fox 2, Carrie Kovarik 3 and Misha Rosenbach 4
(1)
New York Presbyterian Hospital, Columbia University Medical Center, New York, New York, USA
(2)
University of California, San Francisco, San Francisco, California, USA
(3)
Dermatopathology, and Infectious Diseases, University of Pennsylvania, Philadelphia, Pennsylvania, USA
(4)
University of Pennsylvania, Philadelphia, Pennsylvania, USA
Abstract
Invasive aspergillosis is the most common opportunistic fungal infection in the hematopoetic stem cell transplant patient. Prior to the regular use of antifungal prophylaxis, invasive fungal infections caused by Candida were the most common infection, followed by infection by Aspergillus .1 In the 1990s, 90% of Aspergillus infections were due to A. fumigatus ; however A. flavus , A. terreus , A. niger , and A. versicolor are all potential causes of invasive aspergillosis. A. flavus , followed by A. niger , is the most common cause of primary cutaneous disease while A. fumigatus more commonly causes disseminated disease.2 A. glaucus , A. chevalieri , and A. ustus are rare causes of cutaneous disease.3
Aspergillosis
Invasive aspergillosis is the most common opportunistic fungal infection in the hematopoetic stem cell transplant patient. Prior to the regular use of antifungal prophylaxis, invasive fungal infections caused by Candida were the most common infection, followed by infection by Aspergillus .
Invasive aspergillosis occurs in the settings of severe or prolonged neutropenia due to cytotoxic therapy for leukemia or lymphoma, high-dose systemic corticosteroids for transplants or collagen vascular disease, a functional neutrophil defect, long-term immunosuppression for graft versus host disease (GVHD), chronic granulomatous disease, neonates, and burn wounds. It is less common, but not infrequently reported, in organ transplant recipients and human immunodeficiency virus (HIV)-positive patients. In HIV-positive patients, low CD4 counts, cytomegalovirus infection, and neutropenia either due to HIV disease, antiretroviral therapy, or ganciclovir are risk factors for cutaneous aspergillosis.
Aspergillus infection can involve the skin of an immunocompromised patient as either a primary or secondary process. Primary cutaneous aspergillosis is rare in the immunocompetent host and should prompt an evaluation for compromised immune status when the diagnosis is made. Hematogenous dissemination from the skin may occur. Secondary cutaneous aspergillosis is most common in bone marrow transplant recipients and leukemic patients. It arises either from direct invasion of skin from an underlying infected structure such as the nose, sinus, or orbit, or as disseminated lesions from hematogenous spread of infection. In secondary cutaneous aspergillosis, the lungs are usually the initial site of infection.
Aspergillus is a ubiquitous fungus readily isolated from soil, plants, decaying vegetation, food, and water. Nosocomial epidemics of invasive aspergillosis in susceptible patients occur in the hospital environment when large numbers of spores are widely dispersed in the air during construction, renovation, and fire-proofing. This release of spores, coupled with both the interruption of primary host defenses (i.e., the skin and mucosal barrier) and impairment by the underlying disease and chemotherapy of secondary host defenses (i.e., neutrophils and macrophages), allow for nosocomial primary cutaneous aspergillosis to occur.
The lesions of primary cutaneous aspergillosis begin as tender erythematous or purpuric macules or papules that progress to violaceous edematous plaques, often with hemorrhagic bullae. Lesions tend to be large (centimeters) and single or a few grouped lesions if multiple. Lesions then develop dark centers and maintain a peripheral brightly purpuric rim. They may then ulcerate or form black necrotic eschars. The bullous phase of invasive aspergillosis is important to recognize, as potassium hydroxide (KOH) preparation of the hemorrhagic blister roof can provide an immediate presumptive diagnosis.
Less common presentations or morphologies of primary cutaneous aspergillosis include otomycosis
Primary cutaneous aspergillosis in HIV-positive patients is most commonly due to A. fumigatus .
Skin manifestations of secondary or disseminated aspergillosis are uncommon and occur in less than 10% of patients with invasive aspergillosis. However, cutaneous lesions may be the presenting sign of disseminated disease.
Skin biopsy specimens from Aspergillus infected patients demonstrate acute angle, regularly septate, dichotomously branching hyphal elements that may be angioinvasive. The histopathologic differential diagnosis includes several other opportunistic fungi including Fusarium , Scopulariopsis , Pseudallescheria , and Penicillium which appear identical to Aspergillus in tissue. In primary cutaneous disease, the inflammatory infiltrate is superficial or superficial and deep. In secondary cutaneous aspergillosis, the infiltrate is in the deep dermis and subcutaneous fat; intravascular thrombosis with masses of hyphae may be seen. While a skin biopsy is needed to prove invasive disease, isolation in culture of the organism from tissue specimens is needed for definitive identification of the fungus.
Enzyme linked immunoassay (ELISA) testing for the galactomannan antigen may aid in the diagnosis of invasive aspergillosis. Galactomannan is a carbohydrate component of the Aspergillus cell wall that is released during hyphal growth. It requires angioinvasion of the organism to be detected and can be tested in serum, brocheoalveolar lavage fluid, or cerebral spinal fluid. The sensitivity of the test ranges from 65% to 90% and the specificity is 90%; thus, a negative result rules out disease while a positive result requires a second positive to confirm true infection. False negatives occur if patients are tested while on antifungal agents or if there is limited angioinvasion. False positives occur with loss of integrity of gastrointestinal mucosa (mucositis, neonates, GVHD, cytotoxic chemotherapy) or with the use of piperacillin-tazobactam. It is not as widely used as the galactomannan ELISA.
Primary cutaneous aspergillosis has a more favorable prognosis than secondary or disseminated disease. Surgical excision in addition to systemic antifungal therapy may be beneficial for primary cutaneous aspergillosis. Systemic treatment is with antifungal therapy such as amphotericin B, itraconazole, voriconazole, or an echinocandin. Fluconazole is not an effective treatment for aspergillosis.
Figure 11 Purpuric papules and a gray flat bullae due to Aspergillus flavus - photo 1
Figure 1.1.
Purpuric papules and a gray flat bullae due to Aspergillus flavus on the palm of a 7-year-old with acute lymphocytic leukemia (ALL) on the 15th day of chemotherapy, febrile with an absolute neutrophil count of 60 on triple antibiotics
Figure 12 Forty-eight hours later the papules became pustular and the bullae - photo 2
Figure 1.2.
Forty-eight hours later, the papules became pustular and the bullae developed a gray-black necrotic base
Next page
Light

Font size:

Reset

Interval:

Bookmark:

Make

Similar books «Cutaneous Manifestations of Infection in the Immunocompromised Host»

Look at similar books to Cutaneous Manifestations of Infection in the Immunocompromised Host. We have selected literature similar in name and meaning in the hope of providing readers with more options to find new, interesting, not yet read works.


Reviews about «Cutaneous Manifestations of Infection in the Immunocompromised Host»

Discussion, reviews of the book Cutaneous Manifestations of Infection in the Immunocompromised Host and just readers' own opinions. Leave your comments, write what you think about the work, its meaning or the main characters. Specify what exactly you liked and what you didn't like, and why you think so.